ENPP2 and cancer: ATX inhibitors, such as PF-8380, have been introduced as potential anticancer therapeutics due to their ability to suppress the production of LPA, a bioactive lipid known to facilitate oncogenic processes including cancer cell proliferation, invasive behavior, and metastatic dissemination (Bhave et al. 2013; Lee et al. 2018).